Side effects and watch-outs
- ⚠️ Liver toxicity (hepatotoxic — LFTs every 2 weeks mandatory)
- Significant HPTA suppression — PCT required
- Joint pain
- Acne
- Hair loss
- Aggression
- ⚠️ Least studied SARM — long-term safety completely unknown
SARM / Myostatin Inhibitor
YK-11 (Myostatin Inhibitor)
Myostatin inhibitor AND partial androgen receptor agonist. Among the most potent SARMs. Very limited human research. Hepatotoxic in case reports. Least studied SARM.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.